Proof of concept studies for a novel immunotherapy for triple negative Breast cancer and companion diagnostic (2024–2026)

Grant type:
United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program
Researchers:
Funded by:
United States Department of Defense